← Browse by Condition
Medical Condition

stomach neoplasms

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for stomach neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — stomach neoplasms Clinical Trials

How many clinical trials are currently recruiting for stomach neoplasms?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for stomach neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for stomach neoplasms?
stomach neoplasms research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a stomach neoplasms clinical trial?
Eligibility criteria for stomach neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Samsung Medical Center 1 trial
Institut Paoli-Calmettes 1 trial
Shandong Tumor Hospital 1 trial
Parc de Salut Mar 1 trial
Seagen, a wholly owned subsidiary of Pfizer 1 trial

Recruiting Clinical Trials

NCT07607119
Recruiting
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
Enrollment
53 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT02869477
Recruiting
Institut Paoli Calmettes Cardia Cancer Database
Enrollment
2,000 pts
Location
France
Sponsor
Institut Paoli-Calmettes
View Trial →
NCT07309185 Phase 2
Recruiting
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
Enrollment
66 pts
Location
China
Sponsor
Shandong Tumor Hospital
View Trial →
NCT07504913
Recruiting
Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41
Enrollment
505 pts
Location
Spain
Sponsor
Parc de Salut Mar
View Trial →
NCT06131840 Phase 1
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Enrollment
914 pts
Location
United States, Canad...
Sponsor
Seagen, a wholly owned subsidi...
View Trial →
NCT07035587
Recruiting
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Enrollment
1,200 pts
Location
South Korea
Sponsor
Yonsei University
View Trial →
NCT04710758
Recruiting
Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
Enrollment
1,018 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →

Related Conditions

colorectal neoplasms (2) gastric adenocarcinoma (1) locally advanced gastric cancer (1) unresectable gastric cancer (1) cardia (1) validation study (1) carcinoma non small cell lung (1) pancreatic ductal adenocarcinoma (1) gastroesophageal junction adenocarcinoma (1) small cell lung carcinoma (1) lung neoplasms (1) pancreatic neoplasms (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology